133 related articles for article (PubMed ID: 38301529)
1. Mucopolysaccharidosis type VII (Sly syndrome) - What do we know?
Grant CL; López-Valdez J; Marsden D; Ezgü F
Mol Genet Metab; 2024 Mar; 141(3):108145. PubMed ID: 38301529
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of vestronidase alfa enzyme replacement therapy in pediatric subjects < 5 years with mucopolysaccharidosis VII.
Lau HA; Viskochil D; Tanpaiboon P; Lopez AG; Martins E; Taylor J; Malkus B; Zhang L; Jurecka A; Marsden D
Mol Genet Metab; 2022 May; 136(1):28-37. PubMed ID: 35331634
[TBL] [Abstract][Full Text] [Related]
3. Clinical course of sly syndrome (mucopolysaccharidosis type VII).
Montaño AM; Lock-Hock N; Steiner RD; Graham BH; Szlago M; Greenstein R; Pineda M; Gonzalez-Meneses A; Çoker M; Bartholomew D; Sands MS; Wang R; Giugliani R; Macaya A; Pastores G; Ketko AK; Ezgü F; Tanaka A; Arash L; Beck M; Falk RE; Bhattacharya K; Franco J; White KK; Mitchell GA; Cimbalistiene L; Holtz M; Sly WS
J Med Genet; 2016 Jun; 53(6):403-18. PubMed ID: 26908836
[TBL] [Abstract][Full Text] [Related]
4. A new case report of severe mucopolysaccharidosis type VII: diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy.
Furlan F; Rovelli A; Rigoldi M; Filocamo M; Tappino B; Friday D; Gasperini S; Mariani S; Izzi C; Bondioni MP; Gellera C; Venerando A; Villa N; Del Carmen Rodriguez Perez M; Pavan F; Biondi A; Parini R
Ital J Pediatr; 2018 Nov; 44(Suppl 2):128. PubMed ID: 30442200
[TBL] [Abstract][Full Text] [Related]
5. First Report of a Patient with MPS Type VII, Due to Novel Mutations in
Dubot P; Sabourdy F; Plat G; Jubert C; Cancès C; Broué P; Touati G; Levade T
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661765
[TBL] [Abstract][Full Text] [Related]
6. Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring program.
Giugliani R; Gonzalez-Meneses A; Scarpa M; Burton B; Wang R; Martins E; Oussoren E; Hennermann JB; Chabrol B; Grant CL; Sun A; Durand C; Hetzer J; Malkus B; Marsden D; Merritt Ii JL
Orphanet J Rare Dis; 2024 May; 19(1):189. PubMed ID: 38715031
[TBL] [Abstract][Full Text] [Related]
7. Vestronidase alfa: Recombinant human β-glucuronidase as an enzyme replacement therapy for MPS VII.
Cadaoas J; Boyle G; Jungles S; Cullen S; Vellard M; Grubb JH; Jurecka A; Sly W; Kakkis E
Mol Genet Metab; 2020 May; 130(1):65-76. PubMed ID: 32192868
[TBL] [Abstract][Full Text] [Related]
8. Oral manifestations in patients and dogs with mucopolysaccharidosis Type VII.
Kantaputra PN; Smith LJ; Casal ML; Kuptanon C; Chang YC; Nampoothiri S; Paiyarom A; Veerasakulwong T; Trachoo O; Ketudat Cairns JR; Chinadet W; Tanpaiboon P
Am J Med Genet A; 2019 Mar; 179(3):486-493. PubMed ID: 30653816
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis of mucopolysaccharidosis type VII facilitating treatment in neonatal period.
Chandler NJ; Ramachandran V; Beesley C; Otigbah C; Davison J; Ashraf T
Prenat Diagn; 2023 Nov; 43(12):1567-1569. PubMed ID: 37964423
[TBL] [Abstract][Full Text] [Related]
10. The first mucopolysaccharidosis type VII in a Taiwanese girl: A case report and review of the literature.
Lee CL; Chuang CK; Hsu CH; Chiu HC; Tu RY; Lo YT; Chang YH; Lin HY; Lin SP
J Formos Med Assoc; 2022 Mar; 121(3):712-717. PubMed ID: 34420841
[TBL] [Abstract][Full Text] [Related]
11. Mucopolysaccharidosis VII in Brazil: natural history and clinical findings.
Giugliani R; Barth AL; Dumas MRC; da Silva Franco JF; de Rosso Giuliani L; Grangeiro CHP; Horovitz DDG; Kim CA; de Araújo Leão EKE; de Medeiros PFV; Miguel DSCG; Moreira MESA; Dos Santos HMGP; da Silva LCS; da Silva LR; de Souza IN; Nalin T; Garcia D
Orphanet J Rare Dis; 2021 May; 16(1):238. PubMed ID: 34022924
[TBL] [Abstract][Full Text] [Related]
12. The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII.
Wang RY; da Silva Franco JF; López-Valdez J; Martins E; Sutton VR; Whitley CB; Zhang L; Cimms T; Marsden D; Jurecka A; Harmatz P
Mol Genet Metab; 2020 Mar; 129(3):219-227. PubMed ID: 32063397
[TBL] [Abstract][Full Text] [Related]
13. Description of the molecular and clinical characteristics of the mucopolysaccharidosis type VII Iberian cohort.
Gónzalez-Meneses A; Pineda M; Bandeira A; Janeiro P; Ruiz MÁ; Diogo L; Cancho-Candela R
Orphanet J Rare Dis; 2021 Oct; 16(1):445. PubMed ID: 34686181
[TBL] [Abstract][Full Text] [Related]
14. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
[TBL] [Abstract][Full Text] [Related]
15. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
Fox JE; Volpe L; Bullaro J; Kakkis ED; Sly WS
Mol Genet Metab; 2015 Feb; 114(2):203-8. PubMed ID: 25468648
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials.
Qi Y; McKeever K; Taylor J; Haller C; Song W; Jones SA; Shi J
Clin Pharmacokinet; 2019 May; 58(5):673-683. PubMed ID: 30467742
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and genetic mutation analysis of patients with mucopolysaccharidosis type VII in China.
Su X; Zhao X; Yin X; Liu L; Huang Y; Zeng C; Li X; Zhang W
Eur J Med Genet; 2024 Apr; 68():104933. PubMed ID: 38442846
[TBL] [Abstract][Full Text] [Related]
19. Mucopolysaccharidosis type VII as a cause of recurrent non-immune hydrops fetalis.
Cheng Y; Verp MS; Knutel T; Hibbard JU
J Perinat Med; 2003; 31(6):535-7. PubMed ID: 14711113
[TBL] [Abstract][Full Text] [Related]
20. Transgene produces massive overexpression of human beta -glucuronidase in mice, lysosomal storage of enzyme, and strain-dependent tumors.
Vogler C; Galvin N; Levy B; Grubb J; Jiang J; Zhou XY; Sly WS
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2669-73. PubMed ID: 12591953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
